|
NEW!! Biondi, M. J., van Gennip, J., & Feld, J. J. (2025). Striving for universal birth dose hepatitis B vaccination in Canada: data from Ontario make a compelling case. Paediatrics & Child Health, 30(5), 359–363. https://doi.org/10.1093/pch/pxaf024 Krüger, V. M., da Silva, A. L., & Goldani, L. Z. (2025). Low levels of vaccine coverage and immunity against hepatitis B virus in children with hematological malignancies in Brazil. The Brazilian Journal of Infectious Diseases, 29(5), 104575. https://doi-org.ezproxy.uct.ac.za/10.1016/j.bjid.2025.104575 |
Allison, R. D., Patel, M. K., & Tohme, R. A. (2017). Hepatitis B vaccine birth dose coverage correlates worldwide with rates of institutional deliveries and skilled attendance at birth. Vaccine, 35(33), 4094-4098. https://doi.org/10.1016/j.vaccine.2017.06.051
Bascom, S., Miller, S., & Greenblatt, J. (2005). Assessment of perinatal hepatitis B and rubella prevention in New Hampshire delivery hospitals. Pediatrics, 115(5), e594-599. https://doi.org/10.1542/peds.2004-2057
Belle Jarvis, S., Fenton-Lee, T., & Small, S. (2023). Introduction of the Hepatitis B Vaccine—Birth Dose: Methods of Improving Rates in a Milieu of Vaccine Hesitancy. Vaccines, 12(1), 25. https://doi.org/10.3390/vaccines12010025
Bierhoff, M., Angkurawaranon, C., Rijken, M. J., Sriprawa, K., Kobphan, P., Nosten, F. N., van Vugt, M., McGready, R., & Devine, A. (2021). Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: A cost-effectiveness analysis. BMC Pregnancy and Childbirth, 21(1), 157. https://doi.org/10.1186/s12884-021-03612-z
Bierhoff, M., Pinyopornpanish, K., Pinyopornpanish, K., Tongprasert, F., Keereevijit, A., Rijken, M., Chu, C. S., Nosten, F., Perfetto, J., van Vugt, M., Mcgready, R., & Angkurawaranon, C. (2019). Retrospective Review of Documentation Practices of Hepatitis B Immunoglobulin, Birth Dose, and Vaccination at the Hospital of Birth, in Thai Nationals and Migrants in Northern Thailand. Open Forum Infectious Diseases, 6(12), ofz518. https://doi.org/10.1093/ofid/ofz518
Borchardt, S. M., Kocharian, A., Hopfensperger, D., & Davis, J. P. (2016). Prevention of Perinatal Transmission of Hepatitis B Virus: Assessment Among Wisconsin Maternity Hospitals. WMJ : Official Publication of the State Medical Society of Wisconsin, 115(2), 74–79; quiz 80.
Boucheron, P., Lu, Y., Yoshida, K., Zhao, T., Funk, A. L., Lunel-Fabiani, F., Guingané, A., Tuaillon, E., van Holten, J., Chou, R., Bulterys, M., & Shimakawa, Y. (2021). Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: A systematic review and meta-analysis. The Lancet. Infectious Diseases, 21(1), 85–96. https://doi.org/10.1016/S1473-3099(20)30593-4
Bradshaw, C., DiFrisco, E., Schweizer, W., Pavsic, J., Demarco, K., Weckesser, J., ... & Rosenberg, R. E. (2020). Improving birth dose hepatitis B vaccination rates: a quality improvement intervention. Hospital pediatrics, 10(5), 430-437. https://doi.org/10.1542/hpeds.2019-0294
Chang, M.-H., Fischler, B., Blauvelt, B., Ciocca, M., Dhawan, A., Ekong, U., Ni, Y.-H., Porta, G., Sibal, A., DAgostino, D., Wirth, S., Morhan, N., & Schwarz, K. B. (2019). Survey of Impediments to Prevention of Mother-to-infant Transmission of Hepatitis B Virus by International Societies. Journal of Pediatric Gastroenterology and Nutrition, 69(6), 648–654. https://doi.org/10.1097/MPG.0000000000002483
Committee on Infectious Diseases. (2017). Elimination of perinatal hepatitis B: providing the first vaccine dose within 24 hours of birth. Pediatrics, 140(3). https://doi.org/10.1542/peds.2017-1870
Cooper, A., Yusuf, H., Rodewald, L., Malik, T., Pollard, R., & Pickering, L. (2001). Attitudes, practices, and preferences of pediatricians regarding initiation of hepatitis B immunization at birth. Pediatrics, 108(6), E98. https://doi.org/10.1542/peds.108.6.e98
de Villiers, M. J., Gamkrelidze, I., Hallett, T. B., Nayagam, S., Razavi, H., & Razavi-Shearer, D. (2020). Modelling hepatitis B virus infection and impact of timely birth dose vaccine: a comparison of two simulation models. PLoS One, 15(8), e0237525. https://doi.org/10.1371/journal.pone.0237525
de Villiers, M. J., Nayagam, S., & Hallett, T. B. (2021). The impact of the timely birth dose vaccine on the global elimination of hepatitis B. Nature communications, 12(1), 6223. https://doi.org/10.1038/s41467-021-26475-6
Ding, Z., Kang, W., Lu, L., Shen, L., Zhao, Z., Huang, G., Xiong, Q., Li, K., & Kong, Y. (2014). [Evaluation on the efficacy of prevention programs and relevant factors targeting mother-to-infant transmission on hepatitis B virus in Yunnan province]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 35(2), 114–116.
Dionne-Odom, J., Cozzi, G. D., Franco, R. A., Njei, B., & Tita, A. T. N. (2022). Treatment and prevention of viral hepatitis in pregnancy. American Journal of Obstetrics and Gynecology, 226(3), 335–346. https://doi.org/10.1016/j.ajog.2021.09.002
Franco, E., Bagnato, B., Marino, M. G., Meleleo, C., Serino, L., & Zaratti, L. (2012). Hepatitis B: Epidemiology and prevention in developing countries. World journal of hepatology, 4(3), 74. doi: 10.4254/wjh.v4.i3.74
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: A modelling study. (2023). The Lancet. Gastroenterology & Hepatology, 8(10), 879–907. https://doi.org/10.1016/S2468-1253(23)00197-8
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: A modelling study. (2018). The Lancet. Gastroenterology & Hepatology, 3(6), 383–403. https://doi.org/10.1016/S2468-1253(18)30056-6
Hahné, S., van den Hoek, A., Baayen, D., van der Sande, M., de Melker, H., & Boot, H. (2012). Prevention of perinatal hepatitis B virus transmission in the Netherlands, 2003-2007: Children of Chinese mothers are at increased risk of breakthrough infection. Vaccine, 30(9), 1715–1720. https://doi.org/10.1016/j.vaccine.2011.12.071
Hang Pham, T. T., Le, T. X., Nguyen, D. T., Luu, C. M., Truong, B. D., Tran, P. D., Toy, M., & So, S. (2019). Knowledge, attitudes and practices of hepatitis B prevention and immunization of pregnant women and mothers in northern Vietnam. PloS One, 14(4), e0208154. https://doi.org/10.1371/journal.pone.0208154
Hawkins, S. S. (2024). Long-term Implications and Barriers to Use of the Hepatitis B Vaccine at Birth. Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN, 53(6), 594–606. https://doi.org/10.1016/j.jogn.2024.09.008
Hipgrave, D. B., Maynard, J. E., & Biggs, B. A. (2006). Improving birth dose coverage of hepatitis B vaccine. Bulletin of the World Health Organization, 84(1), 65-71. https://www.scielosp.org/pdf/bwho/v84n1/v84n1a16.pdf
Hu, Y., Zhang, S., Luo, C., Liu, Q., & Zhou, Y.-H. (2012). Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: A provincial population-based study in China. BMC Infectious Diseases, 12, 221. https://doi.org/10.1186/1471-2334-12-221
Hutin, Y., Hennessey, K., Cairns, L., Zhang, Y., Li, H., Zhao, L., ... & Hadler, S. (2013). Improving hepatitis B vaccine timely birth dose coverage: lessons from five demonstration projects in China, 2005–2009. Vaccine, 31, J49-J55.https://doi.org/10.1016/j.vaccine.2013.03.025
Implementation of newborn hepatitis B vaccination—Worldwide, 2006. (2008). MMWR. Morbidity and Mortality Weekly Report, 57(46), 1249–1252.
Jin, Y., Geng, N., Zhao, L., Li, Y., Zheng, L., Zhu, W., Sheng, Q., An, Z., Wang, J., Dou, X., & Bai, H. (2020). The Prevalence of HBV Infection: A Retrospective Study of 13 Years in a Public Hospital of Northeast China. Viral Immunology, 33(2), 99–104. https://doi.org/10.1089/vim.2019.0104
Jourdain, G., Ngo-Giang-Huong, N., & Khamduang, W. (2019). Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications. Infection and Drug Resistance, 12, 977–987. https://doi.org/10.2147/IDR.S171695
Juon, H.-S., Sheler, D. T., Pan, J., Le, D., & Yang, Y. T. (2022). Racial Disparities in Hepatitis B Birth Dose in the Washington Metropolitan Region, 2018-2020. Vaccines, 10(7). https://doi.org/10.3390/vaccines10071121
Khue, P. M., Thuy Linh, N. T., Vinh, V. H., Dung, L. V., & Nguyen Van, B. (2020). Hepatitis B Infection and Mother-to-Child Transmission in Haiphong, Vietnam: A Cohort Study with Implications for Interventions. BioMed Research International, 2020, 4747965. https://doi.org/10.1155/2020/4747965
Ko, S. C., Schillie, S. F., Walker, T., Veselsky, S. L., Nelson, N. P., Lazaroff, J., Crowley, S., Dusek, C., Loggins, K., Onye, K., Fenlon, N., & Murphy, T. V. (2014). Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women. Vaccine, 32(18), 2127–2133. https://doi.org/10.1016/j.vaccine.2014.01.099
Li, X., Dumolard, L., Patel, M., Gacic-Dobo, M., & Hennessey, K. (2018). Implementation of hepatitis B birth dose vaccination--worldwide, 2016/Mise en oeuvre de la vaccination contre l'hepatite B par une dose a la naissance a l'echelle mondiale, 2016. Weekly Epidemiological Record, 93(7), 61-73.
Libbus, M. K., & Phillips, L. M. (2009). Public health management of perinatal hepatitis B virus. Public Health Nursing (Boston, Mass.), 26(4), 353–361. https://doi.org/10.1111/j.1525-1446.2009.00790.x
Luo, Y.-L., Gao, S., Zhang, Q.-F., Liu, X., Lv, D.-Y., Chen, J.-H., & Wang, W. (2024). Eliminating mother-to-child transmission of hepatitis B virus: Practice and progress in Baoan, a national pilot district of China. BMC Public Health, 24(1), 58. https://doi.org/10.1186/s12889-023-17500-y
Maiorella, R., & Rodriguez, V. A. (2021). Hepatitis B Vaccine Refusal in the Newborn Period. Pediatric Annals, 50(8), e343–e347. https://doi.org/10.3928/19382359-20210712-01
Massey, J., Nair, A., Dietz, S., Snaman, D., & Bixler, D. (2018). Hospital, Maternal and Birth Factors Associated With Hepatitis B Vaccination at Birth: West Virginia, 2015. The Pediatric Infectious Disease Journal, 37(7), 691–696. https://doi.org/10.1097/INF.0000000000001953
Matthews, P. C., Ocama, P., Wang, S., El-Sayed, M., Turkova, A., Ford, D., Torimiro, J., Garcia Ferreira, A. C., Espinosa Miranda, A., De La Hoz Restrepo, F. P., Seremba, E., Mbu, R., Pan, C. Q., Razavi, H., Dusheiko, G., Spearman, C. W., & Hamid, S. (2023). Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virus. JHEP Reports : Innovation in Hepatology, 5(8), 100777. https://doi.org/10.1016/j.jhepr.2023.100777
Nayagam, S., Thursz, M., Sicuri, E., Conteh, L., Wiktor, S., Low-Beer, D., & Hallett, T. B. (2016). Requirements for global elimination of hepatitis B: a modelling study. The Lancet. Infectious Diseases, 16(12), 1399–1408. https://doi.org/10.1016/S1473-3099(16)30204-3
Nemerofsky, S. L., Akingboye, B., Ferguson, C., & Africa, D. (2018). Sustained improvement in administration of the hepatitis B vaccine birth dose: a quality improvement initiative. American journal of medical quality, 33(3), 313-320. https://doi.org/10.1177/1062860617732635
Noubiap, J. J., & Ndoula, S. T. (2022). Prevention of mother-to-child transmission of hepatitis B: birth-dose vaccination is not enough. The Lancet Global Health, 10(4), e455-e456. https://www.thelancet.com/action/showPdf?pii=S2214-109X%2822%2900046-8
O’Mahony, E., Raghunanan, S., Brown, A., & Foster, C. (2024). Prevention of vertical transmission of hepatitis B: A retrospective review of a 5-year maternal-infant cohort in London. Journal of Paediatrics and Child Health, 60(9), 422–427. https://doi.org/10.1111/jpc.16609
Oram, R. J., Daum, R. S., Seal, J. B., & Lauderdale, D. S. (2001). Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine. JAMA, 285(14), 1874–1879. https://doi.org/10.1001/jama.285.14.1874
Organization, W. H. (2019). Hepatitis B vaccines: WHO position paper, July 2017—Recommendations. Vaccine, 37(2), 223–225. https://doi.org/10.1016/j.vaccine.2017.07.046
Parija, P. P. (2020). Hepatitis B vaccine birth dose in India: time to reconsider. Human vaccines & immunotherapeutics, 16(1), 158-160. https://doi.org/10.1080/21645515.2019.1640557
Patel, M. K., Capeding, R. Z., Ducusin, J. U., de Quiroz Castro, M., Garcia, L. C., & Hennessey, K. (2014). Findings from a hepatitis B birth dose assessment in health facilities in the Philippines: Opportunities to engage the private sector. Vaccine, 32(39), 5140–5144. https://doi.org/10.1016/j.vaccine.2013.11.097
Pattyn, J., Hendrickx, G., Vorsters, A., & Van Damme, P. (2021). Hepatitis B vaccines. The Journal of infectious diseases, 224(Supplement_4), S343-S351. https://doi.org/10.1093/infdis/jiaa668
Pinon, M., Giugliano, L., Nicastro, E., Kakaa, O., Coscia, A., Carbonara, C., ... & Calvo, P. L. (2021). Timely birth dose vaccine to prevent vertical transmission of hepatitis B: a single center experience on the road to the WHO elimination goals in Italy. Vaccines, 9(7), 801. https://doi.org/10.3390/vaccines9070801
Progress in hepatitis B prevention through universal infant vaccination—China, 1997-2006. (2007). MMWR. Morbidity and Mortality Weekly Report, 56(18), 441–445.
Qiao, Y.-P., Su, M., Song, Y., Wang, X.-Y., Li, Z., Li, Y.-L., Dou, L.-X., Wang, Q., Hann, K., Zhang, G.-M., Huang, X.-N., Yang, Y.-N., Jin, X., & Wang, A.-L. (2019). Outcomes of the national programme on prevention of mother-to-child transmission of hepatitis B virus in China, 2016-2017. Infectious Diseases of Poverty, 8(1), 65. https://doi.org/10.1186/s40249-019-0576-y
Sarathy, L., Cirillo, C., Dehn, C., Lerou, P. H., & Prendergast, M. (2021). Improving timeliness of hepatitis B vaccine birth dose administration. Hospital pediatrics, 11(5), 446-453. https://doi.org/10.1542/hpeds.2020-002766
Sarin, S. K., Kumar, M., Eslam, M., George, J., Al Mahtab, M., Akbar, S. M. F., Jia, J., Tian, Q., Aggarwal, R., Muljono, D. H., Omata, M., Ooka, Y., Han, K.-H., Lee, H. W., Jafri, W., Butt, A. S., Chong, C. H., Lim, S. G., Pwu, R.-F., & Chen, D.-S. (2020). Liver diseases in the Asia-Pacific region: A Lancet Gastroenterology & Hepatology Commission. The Lancet. Gastroenterology & Hepatology, 5(2), 167–228. https://doi.org/10.1016/S2468-1253(19)30342-5
Sayre, W., & Thompson, P. (2021). Prevention of Vertical Transmission of Hepatitis B Within a North Carolina Hospital System. Clinical Therapeutics, 43(10), 1786–1791. https://doi.org/10.1016/j.clinthera.2021.08.012
Scheifele, D. W. (2019). Will Infant Hepatitis B Immunization Protect Adults? The Pediatric Infectious Disease Journal, 38(6S Suppl 1), S64–S66. https://doi.org/10.1097/INF.0000000000002326
Seaman, C. P., Morgan, C., Howell, J., Xiao, Y., Spearman, C. W., Sonderup, M., Lesi, O., Andersson, M. I., Hellard, M. E., & Scott, N. (2020). Use of controlled temperature chain and compact prefilled auto-disable devices to reach 2030 hepatitis B birth dose vaccination targets in LMICs: A modelling and cost-optimisation study. The Lancet. Global Health, 8(7), e931–e941. https://doi.org/10.1016/S2214-109X(20)30231-X
Shan, S., Cui, F., & Jia, J. (2018). How to control highly endemic hepatitis B in Asia. Liver International : Official Journal of the International Association for the Study of the Liver, 38 Suppl 1, 122–125. https://doi.org/10.1111/liv.13625
Sobel, H. L., Mantaring III, J. B., Cuevas, F., Ducusin, J. V., Thorley, M., Hennessey, K. A., & Nyunt-U, S. (2011). Implementing a national policy for hepatitis B birth dose vaccination in Philippines: lessons for improved delivery. Vaccine, 29(5), 941-. https://doi.org/10.1016/j.vaccine.2010.11.047
Tang, J., Luo, Y.-Q., & Zhou, Y.-H. (2021). Elimination of hepatitis B virus infection in children: Experience and challenge in China. Chinese Medical Journal, 134(23), 2818–2824. https://doi.org/10.1097/CM9.0000000000001791
Tshering, N., Dhakal, G. P., Wangchuk, U., Wangdi, S., Khandu, L., Pelden, S., Nogareda, F., Patel, M. K., Hutin, Y. J. F., Wannemuehler, K., Rewari, B. B., & Wangchuk, S. (2020). Prevalence of HBV and HCV infections, Bhutan, 2017: Progress and next steps. BMC Infectious Diseases, 20(1), 485. https://doi.org/10.1186/s12879-020-05176-3
Veronese, P., Dodi, I., Esposito, S., & Indolfi, G. (2021). Prevention of vertical transmission of hepatitis B virus infection. World journal of gastroenterology, 27(26), 4182. doi: 10.3748/wjg.v27.i26.4182
Wang, F. Z., Zheng, H., Zhang, G. M., Miao, N., Sun, X. J., & Cui, F. Q. (2017). [Sero-epidemiological analysis on hepatitis B among children aged 1-14 years old born to HBsAg positive mother in China, 2014]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 38(4), 457–461. https://doi.org/10.3760/cma.j.issn.0254-6450.2017.04.009
Wang, F., Zheng, H., Zhang, G., Ding, Z., Li, F., Zhong, G., Chen, Y., Jia, Y., Miao, N., Wu, Z., Sun, X., Li, L., Liang, X., & Cui, F. (2015). Effectiveness of prevention of mother-to-child transmission practice in three provinces of Southern China. Human Vaccines & Immunotherapeutics, 11(8), 2061–2067. https://doi.org/10.1080/21645515.2015.1023972
Wilson, P., Taylor, G., Knowles, J., Blyth, E., Laux, J., Lohr, J., & Jhaveri, R. (2019). Missed hepatitis B birth dose vaccine is a risk factor for incomplete vaccination at 18 and 24 months. Journal of Infection, 78(2), 134-139. https://doi.org/10.1016/j.jinf.2018.09.014
Yonghao, G., Pumei, D., Jianhui, Y., Jin, X., Yanyang, Z., & Zhe, W. (2017). A retrospective study of hepatitis B mother-to-child transmission prevention and postvaccination serological test results of infants at risk of perinatal transmission in two counties of middle China. Journal of Viral Hepatitis, 24(8), 687–695. https://doi.org/10.1111/jvh.12694
Zhang, L., Ko, S., Lv, J., Ji, F., Yan, B., Xu, F., & Xu, A. (2014). Perinatal hepatitis B prevention program in Shandong Province, China. Evaluation and progress. Human Vaccines & Immunotherapeutics, 10(9), 2755–2760. https://doi.org/10.4161/hv.29648
Zhao, H., Zhou, X., & Zhou, Y. H. (2020). Hepatitis B vaccine development and implementation. Human vaccines & immunotherapeutics, 16(7), 1533-1544. https://doi.org/10.1080/21645515.2020.1732166
Zhao, Z., Murphy, T. V., & Jacques-Carroll, L. (2011). Progress in newborn hepatitis B vaccination by birth year cohorts-1998-2007, USA. Vaccine, 30(1), 14–20. https://doi.org/10.1016/j.vaccine.2011.10.076
Accrombessi, M., Adetola, C. V., Bacharou, S., Dossou, Y., Avokpaho, E., Yakoubou, A., Koumakpai-Adeothy, S., Lozes, E., & Issifou, S. (2020). Assessment of the anti-HBs antibody response in Beninese infants following 4 doses of HBV vaccine, including administration at birth, compared to the standard 3 doses regime; a cross-sectional survey. Vaccine, 38(7), 1787–1793. https://doi.org/10.1016/j.vaccine.2019.12.031
Adjei, C. A., Nachinab, G. T.-E., Atibila, F., Ansah-Nyarko, M., Kyei, J. M., & Fosu, P. K. (2022). Determinants and preventive practices of midwives and physicians toward vertical transmission of hepatitis B in Ghana: A cross-sectional survey. The Pan African Medical Journal, 43, 183. https://doi.org/10.11604/pamj.2022.43.183.31794
Adjei, C. A., Suglo, D., Ahenkorah, A. Y., MacDonald, S. E., & Richter, S. (2023). Barriers to Timely Administration of Hepatitis B Birth Dose Vaccine to Neonates of Mothers With Hepatitis B in Ghana: Midwives’ Perspectives. SAGE Open Nursing, 9, 23779608231177547. https://doi.org/10.1177/23779608231177547
Anderson, S., Harper, L. M., Dionne‐Odom, J., Halle‐Ekane, G., & Tita, A. T. (2018). A decision analytic model for prevention of hepatitis B virus infection in Sub‐Saharan Africa using birth‐dose vaccination. International Journal of Gynecology & Obstetrics, 141(1), 126-132. https://doi.org/10.1002/ijgo.12434
Boisson, A., Goel, V., Yotebieng, M., Parr, J. B., Fried, B., & Thompson, P. (2022). Implementation approaches for introducing and overcoming barriers to hepatitis B birth-dose vaccine in sub-Saharan Africa. Global Health: Science and Practice, 10(1).https://www.ghspjournal.org/content/ghsp/10/1/e2100277.full.pdf
Boisson, A., Morgan, C. E., Fried, B., Shea, C. M., Yotebieng, M., Ngimbi, P., ... & Thompson, P. (2022). Barriers and facilitators to timely birth-dose vaccines in Kinshasa Province, the DRC: a qualitative study. Journal of Global Health Reports, 6, e2022028. doi:10.29392/001c.35449
Boisson-Walsh, A., Fried, B., Shea, C. M., Ngimbi, P., Mbonze, N., Tabala, M., Kashamuka, M. M., Babakazo, P., Yotebieng, M., & Thompson, P. (2024). Using intervention mapping to develop an implementation strategy to improve timely uptake of streamlined birth-dose vaccines in the Democratic Republic of the Congo. PLOS Global Public Health, 4(1), e0002641. https://doi.org/10.1371/journal.pgph.0002641
Chotun, N., Preiser, W., van Rensburg, C. J., Fernandez, P., Theron, G. B., Glebe, D., & Andersson, M. I. (2017). Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: A South African experience. PloS One, 12(7), e0181267. https://doi.org/10.1371/journal.pone.0181267
Dionne-Odom, J., Westfall, A. O., Nzuobontane, D., Vinikoor, M. J., Halle-Ekane, G., Welty, T., & Tita, A. T. N. (2018). Predictors of Infant Hepatitis B Immunization in Cameroon: Data to Inform Implementation of a Hepatitis B Birth Dose. The Pediatric Infectious Disease Journal, 37(1), 103–107. https://doi.org/10.1097/INF.0000000000001728
El-Nasser, A. M., Tawfeik, A. M., Abushady, E. A. E., Mohammad, E. A., Elhady, M., Abdul-Mohymen, A. M., & Ali, S. E. I. (2024). Effectiveness of zero dose HBV vaccine on prevention of HBV breakthrough infection among vaccinated Egyptian children. The Egyptian Journal of Immunology, 31(4), 66–75.
Freeland, C., Kanu, F., Mohammed, Y., Nwokoro, U. U., Sandhu, H., Ikwe, H., Uba, B., Asekun, A., Akataobi, C., Adewole, A., Fadahunsi, R., Wisdom, M., Akudo, O. L., Ugbenyo, G., Simple, E., Waziri, N., Vasumu, J. J., Bahuli, A. U., Bashir, S. S., … Tohme, R. A. (2023). Barriers and facilitators to hepatitis B birth dose vaccination: Perspectives from healthcare providers and pregnant women accessing antenatal care in Nigeria. PLOS Global Public Health, 3(6), e0001332. https://doi.org/10.1371/journal.pgph.0001332
Gueye, S. B., Diop-Ndiaye, H., Lo, G., Mintsa, S., Guindo, I., Dia, A., Sow-Sall, A., Gaye-Diallo, A., Mboup, S., & Touré-Kane, C. (2016). HBV carriage in children born from HIV-seropositive mothers in Senegal: The need of birth-dose HBV vaccination. Journal of Medical Virology, 88(5), 815–819. https://doi.org/10.1002/jmv.24409
Guingané, A. N., Bougouma, A., Sombié, R., King, R., Nagot, N., Meda, N., Van de Perre, P., & Tuaillon, E. (2020). Identifying gaps across the cascade of care for the prevention of HBV mother-to-child transmission in Burkina Faso: Findings from the real world. Liver International : Official Journal of the International Association for the Study of the Liver, 40(10), 2367–2376. https://doi.org/10.1111/liv.14592
Howell, J., Lemoine, M., & Thursz, M. (2014). Prevention of materno-foetal transmission of hepatitis B in sub-Saharan Africa: The evidence, current practice and future challenges. Journal of Viral Hepatitis, 21(6), 381–396. https://doi.org/10.1111/jvh.12263
Kramvis, A., & Clements, C. J. (2010). Implementing a birth dose of hepatitis B vaccine for home deliveries in Africa—Too soon?. Vaccine, 28(39), 6408-6410. https://doi.org/10.1016/j.vaccine.2010.07.042
Loarec, A., Nguyen, A., Molfino, L., Chissano, M., Madeira, N., Rusch, B., Staderini, N., Couto, A., Ciglenecki, I., & Antabak, N. T. (2022). Prevention of mother-to-child transmission of hepatitis B virus in antenatal care and maternity services, Mozambique. Bulletin of the World Health Organization, 100(1), 60–69. https://doi.org/10.2471/BLT.20.281311
Moturi, E., Tevi-Benissan, C., Hagan, J. E., Shendale, S., Mayenga, D., Murokora, D., ... & Mihigo, R. (2018). Implementing a birth dose of hepatitis B vaccine in Africa: findings from assessments in 5 countries. Journal of immunological sciences, (5), 31.https://pmc.ncbi.nlm.nih.gov/articles/PMC6436721/pdf/emss-81557.pdf
Okenwa, U. J., Dairo, M. D., Uba, B., & Ajumobi, O. (2019). Maternal reasons for non-receipt of valid Hepatitis B birth dose among mother-infant pairs attending routine immunization clinics, South-east, Nigeria. Vaccine, 37(46), 6894–6899. https://doi.org/10.1016/j.vaccine.2019.09.056
Olakunde, B. O., Itanyi, I. U., Onyeka, T. C., Paintsil, E., Torpey, K., Lasebikan, N., ... & Ezeanolue, E. E. (2024). Hepatitis B vaccine birth dose coverage among hepatitis B-exposed and hepatitis B-unexposed infants: evidence from the Healthy Beginning Initiative program in Benue State, Nigeria. The Pan African Medical Journal, 47, 67. doi: 10.11604/pamj.2024.47.67.40466
Seaman, C. P., Morgan, C., Howell, J., Xiao, Y., Spearman, C. W., Sonderup, M., Lesi, O., Andersson, M. I., Hellard, M. E., & Scott, N. (2020). Use of controlled temperature chain and compact prefilled auto-disable devices to reach 2030 hepatitis B birth dose vaccination targets in LMICs: A modelling and cost-optimisation study. The Lancet. Global Health, 8(7), e931–e941. https://doi.org/10.1016/S2214-109X(20)30231-X
| Shah, S. J., Haque, R., Babatunde, A. O., Akinsolu, F. T., Afadapa, M., Obodoechina, N., ... & Tucker, J. D. (2025, July). Increasing Birth Dose Hepatitis B Vaccination in Nigeria: Qualitative Analysis of Data from a Crowdsourcing Open Call. In Open Forum Infectious Diseases (p. ofaf400). Oxford University Press. https://doi.org/10.1093/ofid/ofaf400 |
Solomon-Rakiep, T., Olivier, J., & Amponsah-Dacosta, E. (2024). Towards contextualized complex systems approaches to scaling-up hepatitis B birth-dose vaccination in the African region: a qualitative systematic review. Frontiers in Public Health, 12, 1389633. https://doi.org/10.3389/fpubh.2024.1389633
Solomon-Rakiep, T., Olivier, J., & Amponsah-Dacosta, E. (2023). Weak adoption and performance of hepatitis B birth-dose vaccination programs in Africa: Time to consider systems complexity? A scoping review. Tropical Medicine and Infectious Disease, 8(10), 474.https://doi.org/10.3390/tropicalmed8100474
Sowe, A., Namatovu, F., Cham, B., & Gustafsson, P. E. (2023). Impact of a performance monitoring intervention on the timeliness of Hepatitis B birth dose vaccination in the Gambia: A controlled interrupted time series analysis. BMC Public Health, 23(1), 568. https://doi.org/10.1186/s12889-023-15499-w
Spearman, C. W. N., & Sonderup, M. W. (2014). Preventing hepatitis B and hepatocellular carcinoma in South Africa: The case for a birth-dose vaccine. SAMJ: South African Medical Journal, 104(9), 610-612. https://www.scielo.org.za/pdf/samj/v104n9/15.pdf
Spearman, C. W., Afihene, M., Ally, R., Apica, B., Awuku, Y., Cunha, L., ... & Sonderup, M. W. (2017). Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. The lancet gastroenterology & hepatology, 2(12), 900-909. https://www.thelancet.com/action/showPdf?pii=S2468-1253%2817%2930295-9
Tamandjou Tchuem, C. R., Andersson, M. I., Wiysonge, C. S., Mufenda, J., Preiser, W., & Cleary, S. (2021). Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis. Vaccine, 39(23), 3141–3151. https://doi.org/10.1016/j.vaccine.2021.04.041
Tamandjou Tchuem, C., Cotton, M. F., Nel, E., Tedder, R., Preiser, W., Violari, A., Bobat, R., Hovind, L., Aaron, L., Montepiedra, G., Mitchell, C., & Andersson, M. I. (2020). Viral hepatitis B and C in HIV-exposed South African infants. BMC Pediatrics, 20(1), 563. https://doi.org/10.1186/s12887-020-02479-x
Tamandjou, C. R., Maponga, T. G., Chotun, N., Preiser, W., & Andersson, M. I. (2017). Is hepatitis B birth dose vaccine needed in Africa?. The Pan African medical journal, 27(Suppl 3), 18. doi: 10.11604/pamj.supp.2017.27.3.11546
Thompson, P., Morgan, C. E., Ngimbi, P., Mwandagalirwa, K., Ravelomanana, N. L. R., Tabala, M., Fathy, M., Kawende, B., Muwonga, J., Misingi, P., Mbendi, C., Luhata, C., Jhaveri, R., Cloherty, G., Kaba, D., Yotebieng, M., & Parr, J. B. (2021). Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: A feasibility study. The Lancet. Global Health, 9(11), e1600–e1609. https://doi.org/10.1016/S2214-109X(21)00304-1
Thompson, P., Parr, J. B., Boisson, A., Razavi-Shearer, D., Ezechi, O. C., Wang, S. H., & Tucker, J. D. (2023). Now is the Time to Scale Up Birth-Dose Hepatitis B Vaccine in Low- and Middle-Income Countries. The Journal of Infectious Diseases, 228(4), 368–370. https://doi.org/10.1093/infdis/jiad026